United Therapeutics Corp banner

United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 544.71 USD 1.66% Market Closed
Market Cap: $23.5B

Wall Street
Price Targets

UTHR Price Targets Summary
United Therapeutics Corp

Wall Street analysts forecast UTHR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for UTHR is 546.81 USD with a low forecast of 427.23 USD and a high forecast of 677.25 USD.

Lowest
Price Target
427.23 USD
22% Downside
Average
Price Target
546.81 USD
0% Upside
Highest
Price Target
677.25 USD
24% Upside
United Therapeutics Corp Competitors:
Price Targets
PTGX
Protagonist Therapeutics Inc
6% Upside
LVS
Las Vegas Sands Corp
30% Upside
GOSS
Gossamer Bio Inc
1 833% Upside
JACK
Jack in the Box Inc
64% Upside
0HQ1
Brooks Automation Inc
68% Upside

Revenue
Forecast

11% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
11% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 14 years the compound annual growth rate for United Therapeutics Corp's revenue is 11%. The projected CAGR for the next 3 years is 10%.

Operating Income
Forecast

9% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
9% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 14 years the compound annual growth rate for United Therapeutics Corp's operating income is 9%. The projected CAGR for the next 3 years is 12%.

Net Income
Forecast

10% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
10% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

For the last 14 years the compound annual growth rate for United Therapeutics Corp's net income is 10%. The projected CAGR for the next 3 years is 7%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is UTHR's stock price target?
Price Target
546.81 USD

According to Wall Street analysts, the average 1-year price target for UTHR is 546.81 USD with a low forecast of 427.23 USD and a high forecast of 677.25 USD.

What is United Therapeutics Corp's Revenue forecast?
Projected CAGR
10%

For the last 14 years the compound annual growth rate for United Therapeutics Corp's revenue is 11%. The projected CAGR for the next 3 years is 10%.

What is United Therapeutics Corp's Operating Income forecast?
Projected CAGR
12%

For the last 14 years the compound annual growth rate for United Therapeutics Corp's operating income is 9%. The projected CAGR for the next 3 years is 12%.

What is United Therapeutics Corp's Net Income forecast?
Projected CAGR
7%

For the last 14 years the compound annual growth rate for United Therapeutics Corp's net income is 10%. The projected CAGR for the next 3 years is 7%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett